Cingulate Therapeutics' Unattributed Round

Cingulate Therapeutics raised a round of funding on November 27, 2013.

Cingulate Therapeutics, LLC (CTx) is a privately held, clinical stage biopharmaceutical company focused on the development of innovative new products for the treatment of Attention Deficit/Hyperactivi…

Articles about Cingulate Therapeutics' Unattributed Round: